Cardiology
Applied Evidence
Hypertension treatment strategies for older adults
This evidence-based review illustrates how to adjust treatment for comorbidities and incorporate frailty and cognitive impairment into the...
Case Reports
Immigrant with stomach pain, distension, nausea, and fever • Dx?
► Abdominal pain and distension
► Nausea
► Declining appetite
Commentary
Skip the antidepressant when the patient has chronic disease?
One can only speculate as to why this antidepressant was not effective in this population.
Photo Rounds
Periorbital ecchymoses and breathlessness
Discoloration resembling “raccoon eyes,” paired with cardiac symptoms, led to the diagnosis.
PURLs
SSRIs for depression/heart failure patients? Not so fast
This study should put to rest the practice of starting SSRIs in depressed patients with heart failure in an attempt to affect CVD outcomes.
HelpDesk
Does treating obstructive sleep apnea improve control of Tx-resistant hypertension?
EVIDENCE-BASED ANSWER: Maybe. Treating obstructive sleep apnea (OSA) with continuous positive airway pressure (CPAP) is associated with decreases...
Original Research
Cervical artery dissection related to chiropractic manipulation: One institution’s experience
This study suggests that patients considering chiropractic cervical spine manipulation should be advised of the risks of potential arterial...
Conference Coverage
Preventive upstream therapy prevents progression of atrial fib
BARCELONA – RACE 3 results highlight benefits of risk factor intervention.
Conference Coverage
A Fib ablation surpasses drugs for improving quality of life
Treatment of paroxysmal or persistent atrial fibrillation with ablation led to a significantly better improvement of quality of life compared with...
Conference Coverage
Dr. Clyde Yancy: CANTOS wows, opens new therapeutic avenues
BARCELONA – Inflammatory pathway for cardiovascular disease and lung cancer found in groundbreaking trial paves way for personalized medicine.
Conference Coverage
VIDEO: Anacetrapib doubles HDL, but patients gain from its modest LDL cut
BARCELONA – Parsing the CTEP inhibitor’s means of conferring benefit proves elusive.